Thromboembolic safety of transdermal hormone therapy

Grzegorz Stachowiak; Tomasz Pertyński

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

6/2008
vol. 7

Send email

Copy url:

abstract:

Thromboembolic safety of transdermal hormone therapy

Grzegorz Stachowiak

,

Tomasz Pertyński

Przegląd Menopauzalny 2008; 6: 285-290

Online publish date: 2009/01/05

View full text Get citation

This article is a review of up-to-date reports – the newest references and own studies – on the influence of transdermal hormone therapy (HT) on thromboembolic risk in menopausal women. The available data testify clearly to the high thromboembolic safety of HT, even when this therapy is administered in women with thromboembolic risk factors.

keywords:

Thromboembolic safety of transdermal hormone therapy

Grzegorz Stachowiak , Tomasz Pertyński

menopause, transdermal hormone therapy, thromboembolic complications

Grzegorz Stachowiak

,

Tomasz Pertyński